CollPlant Biotechnologies Ltd Quarterly Operating Income (Loss) in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CollPlant Biotechnologies Ltd quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2024.
  • CollPlant Biotechnologies Ltd Operating Income (Loss) for the quarter ending June 30, 2024 was -$4.41M, a 178% decline year-over-year.
  • CollPlant Biotechnologies Ltd annual Operating Income (Loss) for 2023 was -$7.51M, a 56.1% increase from 2022.
  • CollPlant Biotechnologies Ltd annual Operating Income (Loss) for 2022 was -$17.1M, a 26403% decline from 2021.
  • CollPlant Biotechnologies Ltd annual Operating Income (Loss) for 2021 was $65K.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.41M -$10.1M -178% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-20
Q2 2023 $5.68M +$9.86M Apr 1, 2023 Jun 30, 2023 6-K 2024-08-20
Q2 2022 -$4.19M -$1.12M -36.6% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-24
Q2 2021 -$3.06M -$1.15M -60.1% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-25
Q2 2020 -$1.91M -$152K -8.63% Apr 1, 2020 Jun 30, 2020 6-K 2021-08-19
Q2 2019 -$1.76M Apr 1, 2019 Jun 30, 2019 6-K 2020-08-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.